{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:32:09Z","timestamp":1793309529915,"version":"4.5.0"},"reference-count":150,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Liver fibrosis represents a wound-healing response to chronic liver injury caused by viral infections, alcohol, and chemicals agents. It is a critical step in the progression from chronic liver disease to cirrhosis and hepatocellular carcinoma. No chemical or biological drugs have been approved for the treatment of liver fibrosis. Relevant studies have demonstrated that effective inhibition of hepatitis B virus (HBV) replication by nucleoside (acid) analogs or polyethylene glycol alpha-interferon can lead to recovery in some patients with hepatitis B liver fibrosis, However, some patients with liver fibrosis do not show improvement, even after achieving a complete serologic and virologic response. A similar situation occurs in patients with hepatitis C-related liver fibrosis. The liver, with its unique anatomical and immunological structure, is the largest immune organ and produces a large number of cytokines in response to external stimuli, which are crucial for the progression of liver fibrosis. cytokines can act either by directly affecting hepatic stellate cells (HSCs) or by indirectly regulating immune target cells. Among these, the interleukin family activates a complex cascade of responses, including cytokines, chemokines, adhesion molecules, and lipid mediators, playing a key role in the initiation and regulation of inflammation, as well as innate and adaptive immunity. In this paper, we systematically summarize recent literature to elucidate the pathogenesis of interleukin-mediated liver fibrosis and explore potential therapeutic targets for liver fibrosis treatment.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1497095","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T05:16:06Z","timestamp":1739164566000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["The role of the interleukin family in liver fibrosis"],"prefix":"10.3389","volume":"16","author":[{"given":"Zixin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.039","article-title":"Hepatic fibrosis: Concept to treatment","volume":"62","author":"Trautwein","year":"2015","journal-title":"J Hepatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5152\/tjg.2018.17330","article-title":"Liver fibrosis","volume":"29","author":"Ayd\u0131n","year":"2018","journal-title":"Turk J Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i17.5138","article-title":"Reversibility and heritability of liver fibrosis: Implications for research and therapy","volume":"21","author":"Atta","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.934755","article-title":"Hepatic stellate cell: A double-edged sword in the liver","volume":"70","author":"Luo","year":"2021","journal-title":"Physiol Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv Drug Delivery Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.07.010","article-title":"Drug targeting to myofibroblasts: Implications for fibrosis and cancer","volume":"121","author":"Yazdani","year":"2017","journal-title":"Adv Drug Delivery Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cytogfr.2018.12.004","article-title":"Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis","volume":"45","author":"Ge","year":"2019","journal-title":"Cytokine Growth Factor Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.652846","article-title":"IL-1 family antagonists in mouse and human skin inflammation","volume":"12","author":"Martin","year":"2021","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i45.12787","article-title":"Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease","volume":"21","author":"Lee","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.3105cm1","article-title":"Interleukin-1 (IL-1) pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci Signal"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1925","article-title":"Structural insights into the assembly and activation of IL-1\u03b2 with its receptors","volume":"11","author":"Wang","year":"2010","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/imr.12614","article-title":"IL-1 and IL-1 regulatory pathways in cancer progression and therapy","volume":"281","author":"Mantovani","year":"2018","journal-title":"Immunol Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and related cytokines in the regulation of inflammation and immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322621","article-title":"Hepatic inflammasome activation as origin of Interleukin-1\u03b1 and Interleukin-1\u03b2 in liver cirrhosis","volume":"70","author":"Praktiknjo","year":"2021","journal-title":"Gut"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.90564.2008","article-title":"Interleukin-1 participates in the progression from liver injury to fibrosis","volume":"296","author":"Gieling","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.01.048","article-title":"Lack of interleukin-1\u03b1 or interleukin-1\u03b2 inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice","volume":"55","author":"Kamari","year":"2011","journal-title":"J Hepatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-018-0032-0","article-title":"Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice","volume":"16","author":"Du","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","article-title":"Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice","volume":"139","author":"Miura","year":"2010","journal-title":"Gastroenterology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22470","article-title":"The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88","volume":"48","author":"Hritz","year":"2008","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10791","article-title":"IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis","volume":"7","author":"Iannitti","year":"2016","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201798321","article-title":"Mechanism of membrane pore formation by human gasdermin-D","volume":"37","author":"Mulvihill","year":"2018","journal-title":"EMBO J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601162","article-title":"Cutting edge: eosinophils undergo caspase-1-mediated pyroptosis in response to necrotic liver cells","volume":"199","author":"Palacios-Macapagal","year":"2017","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.90223.2008","article-title":"Inflammasome-mediated regulation of hepatic stellate cells","volume":"296","author":"Watanabe","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2016.699","article-title":"Nod-like receptor protein 3 inflammasome activation by Escherichia coli RNA induces transforming growth factor beta 1 secretion in hepatic stellate cells","volume":"16","author":"Wang","year":"2016","journal-title":"Bosn J Basic Med Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.cgh.2014.02.024","article-title":"Resveratrol does not benefit patients with nonalcoholic fatty liver disease","volume":"12","author":"Chachay","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1348","article-title":"Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating NLRP3 inflammasome pathway","volume":"67","author":"Wu","year":"2015","journal-title":"IUBMB Life"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2016.05.023","article-title":"Angelica sinensis in China-A review of botanical profile, ethnopharmacology, phytochemistry and chemical analysis","volume":"190","author":"Wei","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2020.06.166","article-title":"Angelica sinensis polysaccharide attenuates CCl4-induced liver fibrosis via the IL-22\/STAT3 pathway","volume":"162","author":"Wang","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1039\/d0fo00660b","article-title":"Pelargonidin ameliorates CCl4-induced liver fibrosis by suppressing the ROS-NLRP3-IL-1\u03b2 axis via activating the Nrf2 pathway","volume":"11","author":"Shi","year":"2020","journal-title":"Food Funct"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1761203","article-title":"Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy","volume":"16","author":"Widjaja","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.545822","article-title":"Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-\u03b2 (TGF-\u03b2) signaling promoting SMAD3 activation and fibrosis via Gremlin protein","volume":"289","author":"O\u2019Reilly","year":"2014","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9162346","article-title":"Effect of entecavir combined with adefovir dipivoxil on clinical efficacy and TNF-\u03b1 and IL-6 levels in patients with hepatitis B cirrhosis","volume":"2021","author":"Yu","year":"2021","journal-title":"J Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7490","article-title":"MicroRNA-146a regulates the transformation from liver fibrosis to cirrhosis in patients with hepatitis B via interleukin-6","volume":"17","author":"Yang","year":"2019","journal-title":"Exp Ther Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217263","article-title":"Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis","volume":"14","author":"Kar","year":"2019","journal-title":"PloS One"},{"key":"B38","article-title":"Is melatonin associated with pro-inflammatory cytokine activity and liver fibrosis in non-alcoholic fatty liver disease (NAFLD) patients","volume":"14","author":"Sohrabi","year":"2021","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3109\/08820139.2015.1137935","article-title":"Trillin reduces liver chronic inflammation and fibrosis in carbon tetrachloride (CCl4) induced liver injury in mice","volume":"45","author":"Tan","year":"2016","journal-title":"Immunol Invest"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1177\/0960327120947453","article-title":"Vinpocetine attenuates thioacetamide-induced liver fibrosis in rats","volume":"40","author":"Elnfarawy","year":"2021","journal-title":"Hum Exp Toxicol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510310123","article-title":"Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice","volume":"31","author":"Kovalovich","year":"2000","journal-title":"Hepatology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23322","article-title":"Lack of interleukin-6\/glycoprotein 130\/signal transducers and activators of transcription-3 signaling in hepatocytes predisposes to liver steatosis and injury in mice","volume":"51","author":"Kroy","year":"2010","journal-title":"Hepatology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50268","article-title":"Interleukin 6\/gp130-dependent pathways are protective during chronic liver diseases","volume":"38","author":"Streetz","year":"2003","journal-title":"Hepatology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27036","article-title":"Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice","volume":"60","author":"Kwon","year":"2014","journal-title":"Hepatology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107158","article-title":"Oncostatin M: A mysterious cytokine in cancers","volume":"90","author":"Masjedi","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i25.8048","article-title":"Fibrogenesis in alcoholic liver disease","volume":"20","author":"Fujii","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176173","article-title":"Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation","volume":"12","author":"Kagan","year":"2017","journal-title":"PloS One"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31658","article-title":"Myeloid-cell-specific IL-6 signaling promotes microRNA-223-enriched exosome production to attenuate NAFLD-associated fibrosis","volume":"74","author":"Hou","year":"2021","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41423-020-00580-w","article-title":"Immunopathobiology and therapeutic targets related to cytokines in liver diseases","volume":"18","author":"He","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/345803","article-title":"Role of IL-17 and Th17 cells in liver diseases","volume":"2011","author":"Hammerich","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203013","article-title":"IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation","volume":"191","author":"Tan","year":"2013","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i8.2062","article-title":"Impaired balance of T helper 17\/T regulatory cells in carbon tetrachloride-induced liver fibrosis in mice","volume":"20","author":"Sun","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28644","article-title":"Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by \u03b3\u03b4 T cells in liver fibrosis","volume":"64","author":"Seo","year":"2016","journal-title":"Hepatology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2017.03.040","article-title":"Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet","volume":"176","author":"Bunney","year":"2017","journal-title":"Physiol Behav"},{"key":"B56","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11010-018-3483-9","article-title":"IL-17A\/IL-17RA promotes invasion and activates MMP-2 and MMP-9 expression via p38 MAPK signaling pathway in non-small cell lung cancer","volume":"455","author":"Wu","year":"2019","journal-title":"Mol Cell Biochem"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxv017","article-title":"Lack of IL-17 signaling decreases liver fibrosis in murine schistosomiasis japonica","volume":"27","author":"Zhang","year":"2015","journal-title":"Int Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179773","article-title":"IL-17A in human liver: significant source of inflammation and trigger of liver fibrosis initiation","volume":"23","author":"Kartasheva-Ebertz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S452061","article-title":"Correlation analysis of IL-17, IL-21, IL-23 with non-alcoholic liver fibrosis and cirrhosis","volume":"17","author":"Yang","year":"2024","journal-title":"J Inflammation Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12876-021-01761-1","article-title":"Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients","volume":"21","author":"Liang","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.47665\/tb.37.4.1093","article-title":"Assessment of interleukin 17 and transforming growth factor-beta 1 in hepatitis C patients with disease progression","volume":"37","author":"Elbanan","year":"2020","journal-title":"Trop Biomed"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12395","article-title":"Neutralization of interleukin-17 attenuates cholestatic liver fibrosis in mice","volume":"83","author":"Zhang","year":"2016","journal-title":"Scand J Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14647","article-title":"Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation","volume":"34","author":"Yamato","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15065","article-title":"Can secukinumab improve liver fibrosis? A pilot prospective study of 10 psoriatic patients","volume":"34","author":"Magdaleno-Tapial","year":"2021","journal-title":"Dermatol Ther"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.008009","article-title":"The three cytokines IL-1\u03b2, IL-18, and IL-1\u03b1 share related but distinct secretory routes","volume":"294","author":"Tapia","year":"2019","journal-title":"J Biol Chem"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2019.11.001","article-title":"The role of interleukin-18 in pancreatitis and pancreatic cancer","volume":"50","author":"Li","year":"2019","journal-title":"Cytokine Growth Factor Rev"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030649","article-title":"Interleukin-18 in health and disease","volume":"20","author":"Yasuda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32776","article-title":"Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis","volume":"77","author":"Knorr","year":"2023","journal-title":"Hepatology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.19540\/j.cnki.cjcmm.20201201.401","article-title":"Effect of extract of Quzhou Aurantii Fructus on hepatic inflammation and NF-\u03baB\/NLRP3 inflammasome pathway in CCl_4-induced liver fibrosis mice","volume":"46","author":"Wang","year":"2021","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1039\/d3fo01315d","article-title":"Ginsenoside Rd, a natural production for attenuating fibrogenesis and inflammation in hepatic fibrosis by regulating the ERR\u03b1-mediated P2X7r pathway","volume":"14","author":"Cui","year":"2023","journal-title":"Food Funct"},{"key":"B71","article-title":"Changes in the IL-18, IL-22, and T lymphocyte subset levels in patients with hepatitis B-related liver cirrhosis and their predictive values for hepatorenal syndrome","volume":"15","author":"Wang","year":"2023","journal-title":"Am J Transl Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1140427","article-title":"Gene polymorphisms of inflammatory factors in liver cirrhosis","volume":"14","author":"Xiao","year":"2023","journal-title":"Front Genet"},{"key":"B73","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccell.2022.01.003","article-title":"Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer","volume":"40","author":"Alam","year":"2022","journal-title":"Cancer Cell"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02432","article-title":"IL-33\/ST2 axis in organ fibrosis","volume":"9","author":"Kotsiou","year":"2018","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abc6259","article-title":"Cellular context of IL-33 expression dictates impact on anti-helminth immunity","volume":"5","author":"Hung","year":"2020","journal-title":"Sci Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.7150\/thno.51648","article-title":"Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2009.00801.x","article-title":"Interleukin-33 overexpression is associated with liver fibrosis in mice and humans","volume":"14","author":"Marvie","year":"2010","journal-title":"J Cell Mol Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5314213","article-title":"IL-33-ST2 axis in liver disease: progression and challenge","volume":"2017","author":"Sun","year":"2017","journal-title":"Mediators Inflamm"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.07.018","article-title":"Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis","volume":"39","author":"McHedlidze","year":"2013","journal-title":"Immunity"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.18335","article-title":"Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis","volume":"8","author":"Vasseur","year":"2017","journal-title":"Oncotarget"},{"key":"B81","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13071-019-3542-4","article-title":"Contribution of tissue transglutaminase to the severity of hepatic fibrosis resulting from Schistosoma japonicum infection through the regulation of IL-33\/ST2 expression","volume":"12","author":"Li","year":"2019","journal-title":"Parasit Vectors"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9259","article-title":"IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2024.01.004","article-title":"The interleukin 33-T helper 2 cell axis promotes human liver fibrosis","volume":"17","author":"Lurje","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2023.12.011","article-title":"Th2 cell activation in chronic liver disease is driven by local IL33 and contributes to IL13-dependent fibrogenesis","volume":"17","author":"Rei\u00dfing","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201747402","article-title":"The IL-33-ST2-MyD88 axis promotes regulatory T cell proliferation in the murine liver","volume":"48","author":"Xu","year":"2018","journal-title":"Eur J Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.04.011","article-title":"Intrahepatic IL-8 producing Foxp3+CD4+ regulatory T cells and fibrogenesis in chronic hepatitis C","volume":"59","author":"Langhans","year":"2013","journal-title":"J Hepatol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jaci.2014.12.1932","article-title":"Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis","volume":"135","author":"MacDonald","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1004077","article-title":"Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis","volume":"187","author":"Katz","year":"2011","journal-title":"J Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2021.104983","article-title":"Genetic variants in IL33 and IL1RL1 genes confer susceptibility to HBV-related liver cirrhosis in Chinese Han population","volume":"94","author":"Ma","year":"2021","journal-title":"Infect Genet Evol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11010057","article-title":"Elevated levels of IL-33, IL-17 and IL-25 indicate the progression from chronicity to hepatocellular carcinoma in hepatitis C virus patients","volume":"11","author":"Askoura","year":"2022","journal-title":"Pathogens"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.09.033","article-title":"PSMP\/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target","volume":"72","author":"She","year":"2020","journal-title":"J Hepatol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2016.63","article-title":"Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells","volume":"15","author":"Tan","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2007.00504.x","article-title":"Cytoprotective effects of melatonin against necrosis and apoptosis induced by ischemia\/reperfusion injury in rat liver","volume":"44","author":"Kim","year":"2008","journal-title":"J Pineal Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00535-022-01936-x","article-title":"Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease","volume":"58","author":"Andoh","year":"2023","journal-title":"J Gastroenterol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.2.1169","article-title":"Four new members expand the interleukin-1 superfamily","volume":"275","author":"Smith","year":"2000","journal-title":"J Biol Chem"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.3.1440","article-title":"Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2","volume":"167","author":"Debets","year":"2001","journal-title":"J Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112258","article-title":"Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation","volume":"209","author":"Franzke","year":"2012","journal-title":"J Exp Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1006\/cyto.2002.0873","article-title":"Interleukin-1F7B (IL-1H4\/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production","volume":"18","author":"Kumar","year":"2002","journal-title":"Cytokine"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169479","article-title":"IL-1 family cytokines in inflammatory dermatoses: pathogenetic role and potential therapeutic implications","volume":"23","author":"Iznardo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.154789","article-title":"Chemokine ligand 20 (CCL20) expression increases with NAFLD stage and hepatic stellate cell activation and is regulated by miR-590-5p","volume":"123","author":"Hanson","year":"2019","journal-title":"Cytokine"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/srep08521","article-title":"Application of IL-36 receptor antagonist weakens CCL20 expression and impairs recovery in the late phase of murine acetaminophen-induced liver injury","volume":"5","author":"Scheiermann","year":"2015","journal-title":"Sci Rep"},{"key":"B102","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.dld.2011.11.013","article-title":"Adenovirus-mediated viral interleukin-10 gene transfer prevents concanavalin A-induced liver injury","volume":"44","author":"Zhou","year":"2012","journal-title":"Dig Liver Dis"},{"key":"B103","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/CEG.S43737","article-title":"Interleukins in chronic liver disease: lessons learned from experimental mouse models","volume":"7","author":"Hammerich","year":"2014","journal-title":"Clin Exp Gastroenterol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14266","article-title":"Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10\/STAT3-suppressed autophagy in hepatocytes","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1177\/15353702221080435","article-title":"Interleukin-10 regulates starvation-induced autophagy through the STAT3-mTOR-p70s6k axis in hepatic stellate cells","volume":"247","author":"Chen","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.113001","article-title":"Interleukin 10 inhibits oxidative stress-induced autophagosome formation in hepatic stellate cells by activating the mTOR-STAT3 pathway","volume":"411","author":"Chen","year":"2022","journal-title":"Exp Cell Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10306","article-title":"Carboxymethyl chitosan prolongs adenovirus-mediated expression of IL-10 and ameliorates hepatic fibrosis in a mouse model","volume":"7","author":"Gou","year":"2022","journal-title":"Bioeng Transl Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2012.1228","article-title":"Interleukin-10 gene modification attenuates hepatocyte activation of rat hepatic stellate cells in vitro","volume":"7","author":"Chen","year":"2013","journal-title":"Mol Med Rep"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.779534","article-title":"Association of IL-9, IL-10, and IL-17 cytokines with hepatic fibrosis in human schistosoma mansoni infection","volume":"12","author":"Franco","year":"2021","journal-title":"Front Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102759","article-title":"Cellular and molecular mechanisms underlying liver fibrosis regression","volume":"10","author":"Caligiuri","year":"2021","journal-title":"Cells"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.245","article-title":"Recent advancement of molecular mechanisms of liver fibrosis","volume":"22","author":"Seki","year":"2015","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28827","article-title":"Dynamics of elastin in liver fibrosis: Accumulates late during progression and degrades slowly in regression","volume":"234","author":"Chen","year":"2019","journal-title":"J Cell Physiol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7254.2006.00304.x","article-title":"Electroporative interleukin-10 gene transfer ameliorates carbon tetrachloride-induced murine liver fibrosis by MMP and TIMP modulation","volume":"27","author":"Chou","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.08.085","article-title":"Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice","volume":"336","author":"Hung","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280611","article-title":"Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin-10 during the course of activation in vitro","volume":"28","author":"Thompson","year":"1998","journal-title":"Hepatology"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4652596","article-title":"Interleukin 10 gene-modified bone marrow-derived dendritic cells attenuate liver fibrosis in mice by inducing regulatory T cells and inhibiting the TGF-\u03b2\/smad signaling pathway","volume":"2019","author":"Xu","year":"2019","journal-title":"Mediators Inflamm"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2022.152315","article-title":"Monocyte-derived immature dendritic cells negatively regulate hepatic stellate cells in vitro by secreting IL-10","volume":"228","author":"Xu","year":"2023","journal-title":"Immunobiology"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111341","article-title":"Interleukin-10 gene intervention ameliorates liver fibrosis by enhancing the immune function of natural killer cells in liver tissue","volume":"127","author":"Chen","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.569575","article-title":"The role of IL-35 in the pathophysiological processes of liver disease","volume":"11","author":"Hu","year":"2021","journal-title":"Front Pharmacol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3152040","article-title":"Interleukin-12p35 deficiency reverses the Th1\/Th2 imbalance, aggravates the Th17\/Treg imbalance, and ameliorates atherosclerosis in ApoE-\/- mice","volume":"2019","author":"Huang","year":"2019","journal-title":"Mediators Inflamm"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1564041","article-title":"The immunomodulatory role of interleukin-35 in fibrotic diseases","volume":"15","author":"Luo","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"101518","DOI":"10.1016\/j.clinre.2020.07.023","article-title":"Interleukin-35: An emerging player in the progression of liver diseases","volume":"45","author":"Zhao","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/819636","article-title":"Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C","volume":"2012","author":"Wang","year":"2012","journal-title":"Mediators Inflamm"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26916","article-title":"Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment","volume":"59","author":"Zhao","year":"2014","journal-title":"Hepatology"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2014.2681","article-title":"Function of interleukin-17 and -35 in the blood of patients with hepatitis B-related liver cirrhosis","volume":"11","author":"Shi","year":"2015","journal-title":"Mol Med Rep"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2014.0142","article-title":"Elevated TGF-\u03b21\/IL-31 pathway is associated with the disease severity of hepatitis B virus-related liver cirrhosis","volume":"28","author":"Ming","year":"2015","journal-title":"Viral Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2014.06.002","article-title":"The expression of a novel anti-inflammatory cytokine IL-35 and its possible significance in childhood asthma","volume":"162","author":"Ma","year":"2014","journal-title":"Immunol Lett"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.244.123","article-title":"Lower plasma levels of IL-35 in patients with primary biliary cirrhosis","volume":"244","author":"Li","year":"2018","journal-title":"Tohoku J Exp Med"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1055\/a-2153-8836","article-title":"Research progress on the role and mechanism of IL-37 in liver diseases","volume":"43","author":"Jiang","year":"2023","journal-title":"Semin Liver Dis"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000003443","article-title":"Expression of IL-37 correlates with immune cell infiltrate and fibrosis in pediatric autoimmune liver diseases","volume":"74","author":"Griessmair","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.603649","article-title":"Modulation of liver inflammation and fibrosis by interleukin-37","volume":"12","author":"Mountford","year":"2021","journal-title":"Front Immunol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s13071-022-05420-6","article-title":"IL-37 alleviates liver granuloma caused by Schistosoma japonicum infection by inducing alternative macrophage activation","volume":"15","author":"Ren","year":"2022","journal-title":"Parasit Vectors"},{"key":"B133","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2015.05.010","article-title":"T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production","volume":"75","author":"Zhu","year":"2015","journal-title":"Cytokine"},{"key":"B134","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ebiom.2018.01.028","article-title":"IL-4 receptor alpha signaling through macrophages differentially regulates liver fibrosis progression and reversal","volume":"29","author":"Weng","year":"2018","journal-title":"EBioMedicine"},{"key":"B135","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/s1386-6346(00)00133-9","article-title":"Th1 and Th2 cytokines differentially regulate the transformation of Kupffer cells into multinucleated giant cells but similarly enhance the Kupffer cell-induced hepatic stellate cell proliferation","volume":"20","author":"Atsukawa","year":"2001","journal-title":"Hepatol Res"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2014.12.001","article-title":"Hepatic stellate cell-conditioned myeloid cells provide a novel therapy for prevention of factor VIII antibody formation in mice","volume":"43","author":"Bhatt","year":"2015","journal-title":"Exp Hematol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2012.03.029","article-title":"Inhibition of allogenic T-cell cytotoxicity by hepatic stellate cell via CD4+ CD25+ Foxp3+ regulatory T cells in vitro","volume":"44","author":"Wu","year":"2012","journal-title":"Transplant Proc"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111045","article-title":"MMP10 alleviates non-alcoholic steatohepatitis by regulating macrophage M2 polarization","volume":"124","author":"Chang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2022.5.05","article-title":"Melatonin attenuates thioacetamide-induced liver fibrosis in male rats through modulation of interleukin-6, interleukin-4, apoptosis and urokinase plasminogen activator receptor-associated protein\/Endo180","volume":"73","author":"Elhadidy","year":"2022","journal-title":"J Physiol Pharmacol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrd4176","article-title":"Therapeutic opportunities of the IL-22-IL-22R1 system","volume":"13","author":"Sabat","year":"2014","journal-title":"Nat Rev Drug Discovery"},{"key":"B141","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00281-009-0188-x","article-title":"Biology of interleukin-22","volume":"32","author":"Wolk","year":"2010","journal-title":"Semin Immunopathol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.38925","article-title":"Interleukin 22 in liver injury, inflammation and cancer","volume":"16","author":"Wu","year":"2020","journal-title":"Int J Biol Sci"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118677","article-title":"Interleukin-22 regulating Kupffer cell polarization through STAT3\/Erk\/Akt crosstalk pathways to extenuate liver fibrosis","volume":"264","author":"Su","year":"2021","journal-title":"Life Sci"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25744","article-title":"Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111015","article-title":"Liposomal IL-22 ameliorates liver fibrosis through miR-let7a\/STAT3 signaling in mice","volume":"124","author":"El-Shorbagy","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1053\/j.gastro.2012.03.044","article-title":"Interleukin-22 promotes proliferation of liver stem\/progenitor cells in mice and patients with chronic hepatitis B virus infection","volume":"143","author":"Feng","year":"2012","journal-title":"Gastroenterology"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27629","article-title":"IL-22 and IL-22 binding protein (IL-22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections","volume":"61","author":"Sertorio","year":"2015","journal-title":"Hepatology"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1111\/acer.15021","article-title":"Interleukin-22 alleviates alcohol-associated hepatic fibrosis, inhibits autophagy, and suppresses the PI3K\/AKT\/mTOR pathway in mice","volume":"47","author":"Meng","year":"2023","journal-title":"Alcohol Clin Exp Res (Hoboken)"},{"key":"B149","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/CS20150405","article-title":"The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice","volume":"130","author":"Rolla","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"B150","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clim.2015.03.003","article-title":"Up-regulation of interleukin-22 mediates liver fibrosis via activating hepatic stellate cells in patients with hepatitis C","volume":"158","author":"Wu","year":"2015","journal-title":"Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1497095\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T05:16:14Z","timestamp":1739164574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1497095\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":150,"alternative-id":["10.3389\/fimmu.2025.1497095"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1497095","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"article-number":"1497095"}}